A medical advocacy organisation says thousands of Kiwi heart patients are missing out on a proven, life-saving heart medication because it is not publicly funded. Kia Manawanui Trust – The Heart of Aotearoa is calling on Pharmac to fund a class of medicines called PCSK9 inhibitors that reduce “bad” cholesterol. Currently funded cholesterol medications aren’t enough to reduce “bad” cholesterol to a safe level for patients living with FH. It’s the reality for thousands of New Zealand families living with FH, an inherited heart disease. “Every day we delay funding vital heart medications means more heart attacks and deaths that could be prevented.”